Clinical trial proposals in paediatric solid tumours, including brain tumours and sarcomas, gynaecological cancers (excluding breast cancer), adult brain tumours and brain metastases, hepatobiliary and pancreatic cancers

Organization
Anticancer Fund
Type
Foundation
Application Due Date
05-01-2022
Comments
For clinical trials in brain metastases, LOI is due 5/1/22.
Brief Description

Our foundation supports clinical investigators in multiple ways that may include financial support if your trial meets our five criteria, has high scientific merit and is in a cancer type of our current focus (see below). We accept co-funding, can consider applications from any country and can financially support any trial phase.

We accept spontaneous applications and regularly, we run Requests for Application with a specific scope.

Spontaneous Application - How to Apply

Do not hesitate to apply for funding if you have a clinical trial proposal meeting our five core criteria in one of the following specific cancer domains:

  • paediatric solid tumours, including brain tumours and sarcomas
  • gynaecological cancers (excluding breast cancer)
  • adult brain tumours and brain metastases
  • hepatobiliary and pancreatic cancers

To assess whether your clinical trial proposal would qualify for full application, we need:

  • a trial synopsis
  • an estimation of the budget you need
  • the amount and source of funding already secured for the trial

This information can be sent to apply@anticancerfund.org. We will rapidly inform you if your proposal is eligible for a full application and you will then receive a submission form to be completed.

Request for Application

In February 2022 we called out for clinical trials in brain metastases. The deadline for the letter of intent is the 1st of May 2022.

More about this call in brain metastases.